Tighe Reardon

Insider Reports History

Entity
Individual
Location
C/O Synthorx, Inc., 11099 North Torrey Pines Road, Suite 190, La Jolla, CA
Signature
/s/ Tighe Reardon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tighe Reardon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Acting Chief Financial Officer Common Stock 3.34M $183M $54.75 Jun 3, 2024 By Avalon BioVentures SPV I, L.P.
Janux Therapeutics, Inc. Acting Chief Financial Officer Common Stock 634K $34.7M $54.75 Jun 3, 2024 By Avalon BioVentures I, LP
Janux Therapeutics, Inc. Acting Chief Financial Officer Common Stock 175K $9.58M $54.75 Jun 3, 2024 Direct
Janux Therapeutics, Inc. Acting Chief Financial Officer Stock Option (right to buy) 157K Jan 2, 2024 Direct

Insider Reports Filed by Tighe Reardon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Jun 3, 2024 2 -$45M 4 Jun 5, 2024 Acting Chief Financial Officer
JANX Janux Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 3, 2024 Acting Chief Financial Officer, 10%+ Owner
JANX Janux Therapeutics, Inc. Nov 13, 2023 1 $4.99M 4 Nov 15, 2023 Acting Chief Financial Officer, 10%+ Owner
JANX Janux Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Acting Chief Financial Officer, 10%+ Owner
JANX Janux Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Acting Chief Financial Officer, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 15, 2021 5 $10.7M 4 Jun 16, 2021 Acting Chief Financial Officer, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 10, 2021 0 $0 3 Jun 10, 2021 Acting Chief Financial Officer, 10%+ Owner